Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 111 Pages
Report ld: 3503979
Request Sample
Customized Report
The global market for Thoracic Endovascular Aneurysm Repair (TEVAR) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Thoracic Endovascular Aneurysm Repair (TEVAR) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Thoracic Endovascular Aneurysm Repair (TEVAR) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Thoracic Endovascular Aneurysm Repair (TEVAR) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Thoracic Endovascular Aneurysm Repair (TEVAR) include Medtronic, Cook Group, W.L. Gore & Associates, Bolton Medical, Gamida Cell, JOTEC GmbH, Getinge, MicroPort Medical, Terumo, Endologix, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Thoracic Endovascular Aneurysm Repair (TEVAR), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thoracic Endovascular Aneurysm Repair (TEVAR) by region & country, by Type, and by Application.
The Thoracic Endovascular Aneurysm Repair (TEVAR) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thoracic Endovascular Aneurysm Repair (TEVAR).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Thoracic Endovascular Aneurysm Repair (TEVAR) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Thoracic Endovascular Aneurysm Repair (TEVAR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Thoracic Endovascular Aneurysm Repair (TEVAR) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Thoracic Endovascular Aneurysm Repair (TEVAR) Product Introduction
1.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Size Forecast
1.2.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value (2020-2031)
1.2.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume (2020-2031)
1.2.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Price (2020-2031)
1.3 Thoracic Endovascular Aneurysm Repair (TEVAR) Market Trends & Drivers
1.3.1 Thoracic Endovascular Aneurysm Repair (TEVAR) Industry Trends
1.3.2 Thoracic Endovascular Aneurysm Repair (TEVAR) Market Drivers & Opportunity
1.3.3 Thoracic Endovascular Aneurysm Repair (TEVAR) Market Challenges
1.3.4 Thoracic Endovascular Aneurysm Repair (TEVAR) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Players Revenue Ranking (2024)
2.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Revenue by Company (2020-2025)
2.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Players Sales Volume Ranking (2024)
2.4 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Company Players (2020-2025)
2.5 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Average Price by Company (2020-2025)
2.6 Key Manufacturers Thoracic Endovascular Aneurysm Repair (TEVAR) Manufacturing Base and Headquarters
2.7 Key Manufacturers Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Thoracic Endovascular Aneurysm Repair (TEVAR)
2.9 Thoracic Endovascular Aneurysm Repair (TEVAR) Market Competitive Analysis
2.9.1 Thoracic Endovascular Aneurysm Repair (TEVAR) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Thoracic Endovascular Aneurysm Repair (TEVAR) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thoracic Endovascular Aneurysm Repair (TEVAR) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Abdominal Aortic Aneurysm
3.1.2 Thoracic Aortic Aneurysm
3.1.3 Cerebral Aortic Aneurysm
3.1.4 Others
3.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type
3.2.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, by Type (2020-2031)
3.2.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, by Type (%) (2020-2031)
3.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Type
3.3.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume, by Type (2020-2031)
3.3.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume, by Type (%) (2020-2031)
3.4 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Male Patients
4.1.2 Female Patients
4.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application
4.2.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, by Application (2020-2031)
4.2.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, by Application (%) (2020-2031)
4.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Application
4.3.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume, by Application (2020-2031)
4.3.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume, by Application (%) (2020-2031)
4.4 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Region
5.1.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Region (2020-2025)
5.1.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Region (2026-2031)
5.1.4 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Region (%), (2020-2031)
5.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Region
5.2.1 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Region (2020-2025)
5.2.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Region (2026-2031)
5.2.4 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume by Region (%), (2020-2031)
5.3 Global Thoracic Endovascular Aneurysm Repair (TEVAR) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
5.4.2 North America Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
5.5.2 Europe Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
5.6.2 Asia Pacific Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
5.7.2 South America Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
5.8.2 Middle East & Africa Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value
6.2.1 Key Countries/Regions Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.3.2 United States Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.4.2 Europe Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.5.2 China Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.6.2 Japan Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.7.2 South Korea Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.8.2 Southeast Asia Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value, 2020-2031
6.9.2 India Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medtronic Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.1.5 Medtronic Recent Development
7.2 Cook Group
7.2.1 Cook Group Company Information
7.2.2 Cook Group Introduction and Business Overview
7.2.3 Cook Group Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Cook Group Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.2.5 Cook Group Recent Development
7.3 W.L. Gore & Associates
7.3.1 W.L. Gore & Associates Company Information
7.3.2 W.L. Gore & Associates Introduction and Business Overview
7.3.3 W.L. Gore & Associates Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 W.L. Gore & Associates Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.3.5 W.L. Gore & Associates Recent Development
7.4 Bolton Medical
7.4.1 Bolton Medical Company Information
7.4.2 Bolton Medical Introduction and Business Overview
7.4.3 Bolton Medical Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Bolton Medical Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.4.5 Bolton Medical Recent Development
7.5 Gamida Cell
7.5.1 Gamida Cell Company Information
7.5.2 Gamida Cell Introduction and Business Overview
7.5.3 Gamida Cell Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Gamida Cell Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.5.5 Gamida Cell Recent Development
7.6 JOTEC GmbH
7.6.1 JOTEC GmbH Company Information
7.6.2 JOTEC GmbH Introduction and Business Overview
7.6.3 JOTEC GmbH Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 JOTEC GmbH Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.6.5 JOTEC GmbH Recent Development
7.7 Getinge
7.7.1 Getinge Company Information
7.7.2 Getinge Introduction and Business Overview
7.7.3 Getinge Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Getinge Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.7.5 Getinge Recent Development
7.8 MicroPort Medical
7.8.1 MicroPort Medical Company Information
7.8.2 MicroPort Medical Introduction and Business Overview
7.8.3 MicroPort Medical Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 MicroPort Medical Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.8.5 MicroPort Medical Recent Development
7.9 Terumo
7.9.1 Terumo Company Information
7.9.2 Terumo Introduction and Business Overview
7.9.3 Terumo Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Terumo Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.9.5 Terumo Recent Development
7.10 Endologix
7.10.1 Endologix Company Information
7.10.2 Endologix Introduction and Business Overview
7.10.3 Endologix Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Endologix Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.10.5 Endologix Recent Development
7.11 Lombard Medical
7.11.1 Lombard Medical Company Information
7.11.2 Lombard Medical Introduction and Business Overview
7.11.3 Lombard Medical Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Lombard Medical Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.11.5 Lombard Medical Recent Development
7.12 Cardinal Health
7.12.1 Cardinal Health Company Information
7.12.2 Cardinal Health Introduction and Business Overview
7.12.3 Cardinal Health Thoracic Endovascular Aneurysm Repair (TEVAR) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Cardinal Health Thoracic Endovascular Aneurysm Repair (TEVAR) Product Offerings
7.12.5 Cardinal Health Recent Development
8 Industry Chain Analysis
8.1 Thoracic Endovascular Aneurysm Repair (TEVAR) Industrial Chain
8.2 Thoracic Endovascular Aneurysm Repair (TEVAR) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Thoracic Endovascular Aneurysm Repair (TEVAR) Sales Model
8.5.2 Sales Channel
8.5.3 Thoracic Endovascular Aneurysm Repair (TEVAR) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Thoracic Endovascular Aneurysm Repair (TEVAR) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 145
USD 3950.00
(Single User License)
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 119
USD 2900.00
(Single User License)
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 98
USD 4250.00
(Single User License)
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 162
USD 4900.00
(Single User License)
The global market for Thoracic Endovascular Aneurysm Repair (TEVAR) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 88
USD 2900.00
(Single User License)
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 89
USD 2900.00
(Single User License)
The global market for Thoracic Endovascular Aneurysm Repair (TEVAR) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 145
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 119
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 98
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 162
The global market for Thoracic Endovascular Aneurysm Repair (TEVAR) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 88
The global Thoracic Endovascular Aneurysm Repair (TEVAR) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now